BCTXW

BriaCell Therapeutics Corp. Warrant

8 hedge funds and large institutions have $3.29M invested in BriaCell Therapeutics Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
3
Closed
Calls
$341K
Puts
$1.67M
Net Calls
-$1.33M
Net Calls Change
+$1.38M
Name Holding Trade Value Shares
Change
Shares
Change %
M
1
Murchinson
Ontario, Canada
$1.08M -$8.33K -4,044 -0.8%
AC
2
Armistice Capital
New York
$772K
PFM
3
Privium Fund Management
Netherlands
$622K +$88.3K +45,306 +17%
KJHP
4
K.J. Harrison & Partners
Ontario, Canada
$581K -$12.1K -4,340 -2%
RAM
5
Redmond Asset Management
Virginia
$144K
ZCA
6
Zeke Capital Advisors
Pennsylvania
$92.7K
UBS Group
7
UBS Group
Switzerland
$2.97K -$3.07K -1,492 -51%
Bank of America
8
Bank of America
North Carolina
$972 +$972 +472 New